期刊文献+

基因兴奋剂与国际反兴奋剂法律法规 被引量:1

Gene Doping and International Anti-doping System
下载PDF
导出
摘要 基因兴奋剂是指非治疗目的使用提高运动能力的基因、遗传构件和(或)细胞.现在的基因兴奋剂主要是与有氧耐力和身体力量相关的基因兴奋剂,与速度相关的基因兴奋剂很少涉及.新兴奋剂的不断出现,使国际反兴奋剂组织不断制定出相应的反兴奋剂法律法规,《反兴奋剂国际公约》由此应运而生.我国在反兴奋剂方面也取得了明显的成绩. Gene doping is multifarious, which can promote the generation of erythrocyte and blood vessel, improve cardiac muscle, increase physical strength and regulate avoirdupois. New dopes keep coming into being, which makes the international anti- doping organizations lay down anti -doping laws constantly and because of this, the International Anti- doping Convention has come into existence. In our country, we have made outstanding achievements in anti -doping.
作者 刘利江 刘辉
出处 《湖州师范学院学报》 2008年第1期79-82,115,共5页 Journal of Huzhou University
关键词 基因 兴奋剂 《反兴奋剂国际公约》 gene doping the International Anti - doping Convention
  • 相关文献

参考文献20

  • 1GALLAGHER R. The straight dope on gene doping [J].Scientist, 2005,19(5) : 6.
  • 2PINCOCK S. Feature - Gene doping [J].Lancet, 2005,366 (Supplement 1 ): 18-19.
  • 3DIAMANTI- KA NDARAKIS E, KONSTANTINOPOULOS P A, PAPAILIOU J, et al. Erythropoietin abuse and erythropoietin gene doping- Detection strategies in the genomic era [J].Sports Medicine, 2005,35(10):831-840.
  • 4VERMA I M. Doping, gene transfer and sport [J].Molecular Therapy, 2004,10 (3) : 405.
  • 5SVENSSON E, BLACK H,DUGGER D. Long term erythropoietin expression in rodents and non - human primates following intramuscular injection of a replication-defective adenoviral vector [J].Human Gene Therapy, 1997,8(15):1797-1806
  • 6LEE M S,LEE J S,LEE J Y. Prevention of erythropoietin- associated hypertension [J].Hypertension, 2007,50(2): 439-456.
  • 7VALE P R, LOSORDO D W, MILLIKEN C E, et al. Phase 1 placebo - controlled,double - blind, dose - escalating trial of myocardial vascular endothelial growth factor 2(VEGF - 2) gene transfer utilizing catheter delivery in patients with chronic myocardial ischemia [J].Circulation, 2001,104(17) : 1214.
  • 8ENGELHARDT S,GRIMMER Y, FAN G H, et al. Constitutive activity of the human beta(1)- adrenergic receptor in beta(1)- receptor transgenic mice [J].Molecular Pharmacology, 2001,60(4):712-717.
  • 9WILLIAMS M L,HATA J A,SCHRODER J ,et al. Targeted beta-adrenergic receptor kinase(beta ARK1) inhibition by gene transfer in failing human hearts [J].Circulation, 2004,109(13):1590-1593.
  • 10HOSHIJIMA M. Gene therapy targeted at calcium handling as an approach to the treatment of heart failure [J].Pharmacology & Therapeutics, 2005,105 (3) : 211 - 228.

同被引文献7

  • 1Stephen p. Feature gene doping [ J ]. Medicine and Sport, 2005,366 : S18 - S19.
  • 2WADA. The world anti - doping code. The 2006 prohibited list. International standard. Keynote address WADA health medical and researeh committee. Montreal :WADA,2005.
  • 3中国新闻网.世界反兴奋剂机构研究可检测基因兴奋剂的系统[EB/OL].http://www.chinanews.com.cn/olympic/news/2008/06-12/1279640.shtml.
  • 4Hacein - Bey - Abina, et al. Sustained correction of X - linked severe combined immunodeficiency by ex vivo gene therapy [ J ]. New England Journal of Medicine,2002,346 : 1185 - 1193.
  • 5联合国教育 科学及文化组织.世界人类基因组与人权宣言[J].中国医学伦理学,1998,2.
  • 6张云龙.基因兴奋剂-引起竞技体育变质的危险分子[N].中国体育报,2005-5-23.
  • 7李和标,李宏.论基因兴奋剂的类型和预防[J].首都体育学院学报,2007,19(2):79-81. 被引量:4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部